Nucleus Software share price has zoomed 6% and is presently trading at Rs 1,480.0.
Meanwhile, the BSE IT index is at 42,222.5 .
Among the top gainers in the BSE IT index today are Mastek (up 3.2%) and INFIBEAM AVENUES (up 2.0%).
Sonata Software (down 0.9%) and Tech Mahindra (down 0.5%) are among the top losers today.
Over the last one year, Nucleus Software has moved up from Rs 1,021.8 to Rs 1,480.0, registering a gain of Rs 458.2 (up 44.8%).
On the other hand, the BSE IT index has moved up from 31,180.8 to 42,222.5, registering a gain of 35.4% during the last 12 months.
The top gainers among the BSE IT index stocks during this same period were Oracle Financial Services (up 178.3%), INFIBEAM AVENUES (up 124.3%) and Firstsource Solutions (up 107.3%).
Must See: These Segments are Witnessing Incredible Growth with Modi's Push
The BSE Sensex is at 80,708.4 (down 0.1%).
The top losers among the BSE Sensex today are Ultratech Cement (down 1.9%) and ICICI Bank (down 0.9%). The most traded stocks in the BSE Sensex are Tata Steel and Tata Motors.
In the meantime, NSE Nifty is at 24,697.8 . Ultratech Cement and ICICI Bank are among the top losers in NSE NIFTY.
Over the last 12 months, the BSE Sensex has moved up from 65,216.1 to 80,708.4, registering a gain of 15,492.3 points (up 23.8%).
Nucleus Software net profit fell 43.6% YoY to Rs 302 million for the quarter ended June 2024, compared to a profit of Rs 536 million a year ago. Net sales declined 5.5% to Rs 1,954 million during the period as against Rs 2,068 million in April-June 2023.
For the year ended March 2024, Nucleus Software reported 49.9% increase in net profit to Rs 1,916 million compared to net profit of Rs 1,278 million during FY23. Revenue of the company grew 30.3% to Rs 8,265 million during FY24.
The current Price to earnings ratio of Nucleus Software, based on rolling 12 month earnings, stands at 23.6.
Equitymaster requests your view! Post a comment on "Nucleus Software Gains 6%; BSE IT Index Up 0.0%". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!